Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03345784 · MORE INFO

Limitations, agreements, and source contact

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers · Source last updated 2024-02-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
limitations And Caveats
description
The main limitation of our study is the small number of patients enrolled due to premature closure; yet the study showed the limiting toxicities of this triplet combination.
point Of Contact
email
stephanie.lheureux@uhnresearch.ca
organization
University Health Network, Princess Margaret Cancer Centre
phone
416-946-2818
title
Dr. Stephanie Lheureux, PI
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
limitations And Caveats
description
The main limitation of our study is the small number of patients enrolled due to premature closure; yet the study showed the limiting toxicities of this triplet combination.
point Of Contact
email
stephanie.lheureux@uhnresearch.ca
organization
University Health Network, Princess Margaret Cancer Centre
phone
416-946-2818
title
Dr. Stephanie Lheureux, PI

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice